Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Surmodics is an established leader in surface modification and drug-delivery coatings for medical devices as well as components for in vitro diagnostic tests. It has pioneered lubricious and hemocompatible coatings used on intravascular devices and provides critical reagents/substrates for immunoassays and microarrays. The company divested its pharmaceuticals business to Evonik in 2011 but remains active with two main segments—Medical Device and In Vitro Diagnostics—serving global medtech/diagnostics markets. No direct clinical trial results are reported since it is not a therapeutic developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suremedix.